A detailed history of Charles Schwab Investment Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 184,315 shares of BIO stock, worth $61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
184,315
Previous 230,656 20.09%
Holding current value
$61 Million
Previous $63 Million 2.1%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$263.97 - $344.64 $12.2 Million - $16 Million
-46,341 Reduced 20.09%
184,315 $61.7 Million
Q2 2024

Aug 12, 2024

BUY
$268.26 - $339.48 $1.94 Million - $2.45 Million
7,215 Added 3.23%
230,656 $63 Million
Q1 2024

May 08, 2024

BUY
$304.11 - $351.99 $2.8 Million - $3.24 Million
9,207 Added 4.3%
223,441 $77.3 Million
Q4 2023

Feb 06, 2024

BUY
$269.37 - $365.04 $2.7 Million - $3.67 Million
10,040 Added 4.92%
214,234 $69.2 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $926,411 - $1.12 Million
2,645 Added 1.31%
204,194 $73.2 Million
Q2 2023

Aug 09, 2023

BUY
$359.49 - $486.4 $407,302 - $551,091
1,133 Added 0.57%
201,549 $76.4 Million
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $1.89 Million - $2.28 Million
4,526 Added 2.31%
200,416 $96 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $4.06 Million - $5.26 Million
11,543 Added 6.26%
195,890 $82.4 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $1.58 Million - $2.15 Million
3,824 Added 2.12%
184,347 $76.9 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $3.06 Million - $3.94 Million
6,597 Added 3.79%
180,523 $89.4 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $2.84 Million - $3.98 Million
5,416 Added 3.21%
173,926 $98 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $3.36 Million - $3.76 Million
4,735 Added 2.89%
168,510 $127 Million
Q3 2021

Nov 16, 2021

BUY
$657.71 - $825.77 $3.3 Million - $4.15 Million
5,024 Added 3.16%
163,775 $122 Million
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $2.44 Million - $2.74 Million
4,227 Added 2.74%
158,751 $102 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $227,009 - $274,875
415 Added 0.27%
154,524 $88.3 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $2.07 Million - $2.61 Million
-4,063 Reduced 2.57%
154,109 $89.8 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $974,297 - $1.15 Million
2,144 Added 1.37%
158,172 $81.5 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $9.35 Million - $13.8 Million
27,911 Added 21.79%
156,028 $70.4 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $619,219 - $791,550
1,935 Added 1.53%
128,117 $44.9 Million
Q4 2019

Feb 07, 2020

BUY
$319.73 - $374.2 $215,178 - $251,836
673 Added 0.54%
126,182 $46.7 Million
Q3 2019

Nov 08, 2019

BUY
$304.55 - $345.24 $3.23 Million - $3.67 Million
10,616 Added 9.24%
125,509 $41.8 Million
Q2 2019

Aug 09, 2019

BUY
$286.93 - $312.59 $235,282 - $256,323
820 Added 0.72%
114,893 $35.9 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $1.78 Million - $2.52 Million
7,945 Added 7.49%
114,073 $34.9 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $361,404 - $507,378
1,642 Added 1.57%
106,128 $24.6 Million
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $8.78 Million - $9.9 Million
-30,361 Reduced 22.52%
104,486 $32.7 Million
Q2 2018

Aug 08, 2018

BUY
$244.1 - $303.88 $1.58 Million - $1.96 Million
6,460 Added 5.03%
134,847 $38.9 Million
Q1 2018

May 07, 2018

BUY
$233.97 - $274.11 $1.29 Million - $1.52 Million
5,533 Added 4.5%
128,387 $32.1 Million
Q4 2017

Jan 17, 2018

BUY
$216.94 - $271.3 $939,784 - $1.18 Million
4,332 Added 3.66%
122,854 $29.3 Million
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $25.2 Million - $28.7 Million
118,522
118,522 $26.3 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.